Showing 61 - 80 of 1155 results
The Australian Nuclear Science and Technology Organisation (ANSTO) has joined a team, lead by the US Department of Energy’s Pacific Northwest National Laboratory (PNNL), to install a high resolution monitoring system at ANSTO’s medical isotope production facility in Lucas Heights, Australia.
Professor Peter Lay from the University of Sydney has been awarded the Australian Synchrotron Lifetime Contribution Award by ANSTO, the Australian Nuclear Science and Technology Organisation.
The first experimental evidence to validate a newly published universal law that provides insights into the complex energy states for liquids has been found using an advanced nuclear technique at ANSTO.
In early February, ANSTO was honoured to host the International Atomic Energy Agency (IAEA) National Liaison Officers Meeting and Sub Regional Approach to the Pacific Islands (SAPI) Programme, which focused on the development and delivery of the IAEA Technical Cooperation Programme in the Pacific.
ANSTO is participating in a new Australian Research Council (ARC) Centre of Excellence for Indigenous and Environmental Histories and Futures (CIEHF) to be headquartered at James Cook University (JCU) that aims to bring Indigenous and environmental histories to the forefront of land and sea management.
International research led by Monash University and the Peter Doherty Institute for Infection and Immunity has achieved a proof of concept for a new, fast, portable saliva screening test that uses an infrared light technology to confirm infection with SARS-CoV-2.
ANSTO radiocarbon facilities and scientists are featured in a new IMAX documentary film released in the United States.
ANSTO has made a contribution to the successful NASA/JPL Ingenuity helicopter flight on Mars through instrument scientist, Dr Andrew Nelson, who was one of the many developers of the open-source software SciPy used in the flight.
The ANSTO Awards in Nuclear Science and Technology 2018 were presented on Friday 2 November at The Australian Museum, and showcased ANSTO’s unique nuclear science and technology capabilities, which enable progress in the key areas of health research and innovation for industry.
A team of ANSTO health researchers, staff at the Centre for Accelerator Science and Dr Melanie Ferlazzo, a postdoc from the French National Institute of Health and Medical Research (INSERM), and scientists from the French Space Agency (CNES), are collaborating on investigations to determine the impact of secondary particles on human cells using the new microprobe beamline at ANSTO’s Centre for Accelerator Science.